Background: Patients with high-risk neuroblastoma (NB) have a 5-year event-free survival of less than 50 %, and novel and improved treatment options are needed. Radiolabeled somatostatin analogs (SSTAs) could be a treatment option.
A. Romiani +12 more
doaj +1 more source
Aim. To study the relationship between the clinical course of myocardial infarction (MI) with changes in left ventricular (LV) geometry and myocardial accumulation of the somatostatin analogue 99mTc-octreotide according to cardiac single-photon emission ...
V. V. Ryabov +5 more
doaj +1 more source
Greetings from below the aortic arch! The paradigm of cardiac paraganglioma. [PDF]
Heufelder, Armin E., Hofbauer, Lorenz C.
core +1 more source
Octreotide for prevention of delayed bleeding after endoscopic mucosal resection for large superficial non-ampullary duodenal tumors. [PDF]
Van De Leur CM +3 more
europepmc +1 more source
Sustained remission of post-Fontan protein-losing enteropathy achieved by combination therapy with high-dose spironolactone and the somatostatin analogue octreotide: a case report. [PDF]
Suzuki E +10 more
europepmc +1 more source
Conservative management of a delayed enterocutaneous fistula following emergency distal gastrectomy using sequential somatostatin analogues. [PDF]
Zalums A, Hibberd A.
europepmc +1 more source
Use of Octreotide in Chylothorax With Mediastinal Mass of Unknown Behaviour: A Case Report. [PDF]
Geronimo AJ, Monis M.
europepmc +1 more source
Yttrium-90 Radioembolization Versus Transarterial Embolization for Lung Carcinoid Hepatic Metastasis. [PDF]
Yuan G +10 more
europepmc +1 more source
Somatostatin and its analogs in the management of postoperative pancreatic fistulas: A comprehensive review. [PDF]
Lazaridou L +6 more
europepmc +1 more source

